APS

BIOLOGICAL5 trials

Sponsors

University of Wisconsin, Madison, Zimmer Biomet, RISE Collaborative

Conditions

Elder AbuseOsteoarthritis, KneeSedationSelf-Neglect

Phase 1

Safety of NStride Autologous Protein Solution in the Treatment of Knee Osteoarthritis (PROGRESS I)

CompletedNCT02262364

Zimmer BiometOsteoarthritis, Knee

Start: 2014-11-30End: 2016-10-31Updated: 2019-02-15

Unknown Phase

The Utility of Pretracheal Stethoscope in Detecting Respiratory Abnormalities in Sedated Children

CompletedNCT01957566

University of Wisconsin, MadisonSedation

Start: 2015-02-28End: 2017-03-22Updated: 2018-12-26

APSS-33-00: A Multicenter, Pilot Study of Autologous Protein Solution (APS) in Knee Osteoarthritis (OA)

CompletedNCT02138890

Zimmer BiometOsteoarthritis, Knee

Start: 2014-05-31End: 2020-09-15Updated: 2021-02-05

Prospective Post-Market Data Collection on Patients With Knee OA and Treated With nSTRIDE APS

CompletedNCT02580643

Zimmer BiometOsteoarthritis, Knee

Start: 2016-05-31End: 2019-06-30Updated: 2020-06-11

Replication and Evaluation of the RISE-APS Model In New Contexts

Not yet recruitingNCT07368257

RISE CollaborativeElder Abuse, Self-Neglect

Start: 2026-01-30End: 2027-09-15Target: 300Updated: 2026-01-26

Related Papers

Autologous Protein Solution Injections for the Treatment of Knee Osteoarthritis: 3-Year Results

The American Journal of Sports Medicine2020-09-0144 citations

Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial

The American Journal of Sports Medicine2017-10-1095 citations

Human blood‐based anti‐inflammatory solution inhibits osteoarthritis progression in a meniscal‐tear rat study

Journal of Orthopaedic Research®2017-01-3123 citations

White blood cell concentration correlates with increased concentrations of IL‐1ra and improvement in WOMAC pain scores in an open‐label safety study of autologous protein solution

Journal of Experimental Orthopaedics2016-01-0140 citations